Axcelis Launches Purion H6 High-Current Ion Implanter
Axcelis Technologies has rolled out a new high-current ion implanter aimed squarely at the next wave of semiconductor manufacturing. The company says its Purion H6 system is designed to deliver higher purity, tighter process control, and stronger productivity for advanced device nodes.
For eeNews Europe readers following equipment innovation, this launch matters because ion implantation remains a critical step across logic, memory, image sensors, and mature nodes. Improvements in dose control, contamination reduction, and throughput directly impact yield, cost of ownership, and fab efficiency — key concerns for both IDMs and foundries.
Building on the Purion H platform
Introduced on February 4, the Purion H6 builds on Axcelis’ established Purion H product line, adding new technologies to support advanced semiconductor devices. The system combines a high-throughput beamline with enhancements in source life, particle control, and dosimetry, targeting both performance and operational efficiency.
According to Axcelis, the Purion H6 is designed as a single solution that can address a wide range of high-current implant applications. These include advanced logic and memory, as well as image sensors and mature technology segments where cost control and uptime are especially critical. The company highlights ease of use, system reliability, and a lower cost of ownership as key outcomes of the redesign.
President and CEO Dr. Russell Low said, “We’re excited to launch the new Purion H6 next generation high current ion implanter, designed to support our customers’ most advanced semiconductor device manufacturing challenges. Axcelis is focused on innovative implant solutions that drive the process performance and Cost of Ownership required to enable major device inflections in logic, advanced memory, image sensor and mature technology market segments.
Focus on dose control and productivity
Axcelis is positioning the Purion H6 around several technical advantages. A next-generation dose control system is intended to improve repeatability and wafer safety while lowering operating costs. Moreover, inhanced particle control, achieved through beamline optimization, is designed to reduce contamination, improve yield, and cut preventive maintenance frequency.
The system also incorporates Axcelis’ Eterna ELS7 source technology, which the company says improves beam stability and repeatability while extending source life and simplifying maintenance. In terms of output, Axcelis claims best-in-class productivity, citing the highest beam currents in its category to support industry-leading throughput.
Executive Vice President Dr. Greg Redinbo commented, “Designed in close collaboration with our customers, we’ve created a platform that sets new benchmarks in implant purity, precision and productivity. The new system introduces an innovative new dose control technology and enhanced beamline optimization — achieving exceptional implant process control while delivering best-in-class productivity, and capital efficiency.”
Market presence and next steps
Axcelis plans to showcase the Purion H6 at SEMICON Korea, taking place February 11–13 at COEX in Seoul, where the system will be on display at booth D522. Additional details, including a product video, are available on the company’s website.
If you enjoyed this article, you will like the following ones: don't miss them by subscribing to :
